Biomarker Services (Luminex/Mescoscale)
Pharmacelsus supports the entire process of preclinical drug development: pharmacokinetics, pharmacodynamics, toxicology, in order to predict the risk of harmful reactions and help you to choose the most suitable candidate for clinical trials.
Using leading-edge multi-array technologies we offer multiplex high-throughput detection, quantification and characterization of Biomarkers (cytokines, hormones, enzymes) and Biopharmaceuticals (e.g. monoclonal antibodies) in different biological matrices from pre-clinical (non-GLP/GLP) as well as clinical studies (GCLP).
These technologies require only small sample volumes, while it doesn‘t mater if it has its origin in in-vitro or in-vivo sources. They allow multiple readouts on a single sample with high sensitivity and reliability.
www.gba-group.com/en/pharma/preclinical-services
Kontakt:
Pharmacelsus GmbH
Science Park 2
66123 Saarbrücken
Phone: +49 681 3946 75-10
info@pharmacelsus.com
Hereon-Institut, Katarzyna Polak-Kraśna
Jan Krönke